Slide 1: Investor Presentation
Investor Presentation February 2026
Slide 2: Forward-Looking Statements
This presentation contains forward-looking statements within the meaning of the Private Securities litigation Reform Act of 1995. Statements in this presentation that are not statements of historical fact are considered forward-looking statements, which are usually identified by the use of words suc
Slide 3: Our Vision: Transform cataract surgery outcomes via adjustability
OUR VISION Transform cataract surgery outcomes via the power of adjustability
Slide 4: RxSight Today
RxSight Today ~500 1,100+ ~300K 1,100+ Employees Ophthalmic LAL Procedures Ophthalmic Offices With Since Inception Offices With LDDs LDDs 2,500+ ~10% $225M+ Surgeons of US Premium Cash, Cash Trained IOL Market Equivalents & ST Investments
Slide 5: Cataract & Lens Replacement Surgery Premium Intraocular Lenses
Cataract & Lens Premium Replacement Surgery Intraocular Lenses Key focus for patients, practices and One of the most common global ophthalmic industry for clinical surgical procedures and financial reasons Intraocular Lens (IOL) Toric (fixed) PC-IOL (fixed) Natural lens IOL provides focusing power A
Slide 6: Fixed versus Adjustable: Rethinking the Patient Journey
Fixed versus Adjustable: Rethinking the Patient Journey Fixed Lens Workflow Choose lens and Perform Outcome approximate power surgery Adjustable Lens Workflow Office-based light treatments Choose LAL and Perform personalize the Real-World Patient Experience Drives approximate power surgery LAL to ea
Slide 7: The Ability to Adjust the Lens After Surgery Delivers Unmatched Refractive Precision
The Ability to Adjust the Lens After Surgery Delivers Unmatched Refractive Precision LAL eyes have better odds of achieving optimal visual outcomes (absolute MRSE and MRCyl ≤ 0.50 D)1 Other Lenses LAL 1. Data on file - RxSight Post-Approval Study
Slide 8: Adjustability is Becoming a Foundation of Premium Outcomes
Adjustability is Becoming a Foundation of Premium Outcomes Adjustability Offers: • Targeted refractive accuracy Quality of vision • Customization to patient lifestyle Adjustability • High patient satisfaction and confidence Binocular range of vision
Slide 9: Growing Data Set and Clinical Consensus
Growing Data Set and Clinical Consensus Real world data from over 3,000 eyes 1 LAL Customer Survey ACCURACY BINOCULAR QUALITY PREFERENCE OUTCOMES >94% >90% 90% 79% +/- MRSE 1 believe LAL provides would select for their 20/25 distance and highest quality of own premium IOL J2 near without vision 2 su
Slide 10: Adjustability Drives Superior Practice Economics
Boosting profitability through premium IOL adoption Adjustability Drives Superior Practice Economics Expand the Premium Market Command a Premium Price Unify the Care Team $2,064 1 Data shows 40% of LAL Patients demonstrate a Enables both surgeons Average additional patients would have high willingne
Slide 11: Historical Trends
Historical Trends LAL Units LDD Installed Base 109,615 1,134 98,055 971 666 54,873 400 25,284 206 4,471 8,328 92 2020 2021 2022 2023 2024 2025 2020 2021 2022 2023 2024 2025 Total Revenue (in millions) $139.9 $134.5 $89.1 $49.0 $22.6 $14.7 2020 2021 2022 2023 2024 2025
Slide 12: Driving Growth Through Utilization Expansion and Surgeon Access
Driving Growth Through Utilization Expansion and Surgeon Access Utilization Growth Expanding Surgeon Access (Same-Store Sales) Through Multiple Paths • Increased procedures per trained surgeon • New LDD placements in additional practices • Driven by training, confidence, • Incremental surgeons withi
Slide 13: Making Personalized Cataract Surgery Faster, Simpler, and More Precise
Future Innovation Making Personalized Cataract Surgery Faster, Simpler, and More Precise Workflow Expanded Efficiency Capabilities
Slide 14: A Large, Underpenetrated Global Premium Opportunity
A Large, Underpenetrated Global Premium Opportunity 1X 4X Key OUS markets make up >80% of global procedures with growing procedure potential 1 Progress to Date • Team buildout and regulatory Next Steps • Focus on initial target markets • KOL development, early installs 1. Market Scope 2025 Premium C
Slide 15: Adjustability Wins Long-Term
Adjustability Wins Long-Term RxSight offers the only Adjustable IOL Market & Platform Execution & Growth Revenue & Margin Financial Strength Optionality Expansion Strength Large, growing market Structural improvements in Utilization-led growth Strong balance sheet commercial execution to fund growth
Slide 16: Thank You
fa RxSIGHT. Thank You &,, of ce a Ff @ o G4AT